Overview

Glycemic Control and Variability for Congestive Heart Failure Exacerbation

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
High glucose as well as fluctuations (rapid swings) in blood glucose can contribute to severe hospital complications and even death.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kathleen Dungan
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Insulin
Insulin, Globin Zinc